Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will eventually ...

INDIANAPOLIS (WISH) — Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana.

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will invest $50 billion in the United States over the next five years, expanding its ...

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...

Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring. A specific location was not disclosed. It also said “significant” expansions and upgrades were ...

INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...

Indiana, Massachusetts and Pennsylvania. Some of the $50 billion in investments were already underway or planned for the next several years, Roche spokesperson Rebekka Schnell said in an e-mail, ...

INDIANAPOLIS (WISH) — Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana.

Roche will add more than 12,000 new jobs as it grows its U.S. operations with new and upgraded production and research sites.

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will ...

Indiana, Massachusetts and Pennsylvania. Some of the $50 billion in investments were already underway or planned for the next several years, Roche spokesperson Rebekka Schnell said in an e-mail ...